glp-1 receptor agonists and cancer risk in adults with obesity GLP-1s may reduce related risk, new research shows. Across large observational cohorts, they were linked to reduced rates of endometrial, liver, colorectal, other cancers. Learn more at the link GLP-1 Agonists For Obesity In

Presented for research literature review only Tolba RH et al

After reconstitution: refrigerate at 28 C and protect from light GHK-Cus copper complex is light-sensitive

+ Lemon Bottle is a brand-formulated injectable fat dissolver made up of riboflavin (vitamin B2), lecithin (a phospholipid that emulsifies fat) and bromelain (a plant-derived enzyme that supports the breakdown of fat)

Available from: Butler J, Shah SJ, Petrie MC, Borlaug BA, Abildstrm SZ, Davies MJ et al (2024) Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism